Regenxbio Inc (RGNX)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	-268,128	-262,876	159,980	-119,233	-148,998
Total assets	US$ in thousands	573,970	833,268	1,113,900	708,164	497,908
Operating ROA		-46.71%	-31.55%	14.36%	-16.84%	-29.92%

December 31, 2023 calculation

Operating ROA = Operating income ÷ Total assets
= $-268,128K ÷ $573,970K
= -46.71%

Regenxbio Inc's operating return on assets (operating ROA) has exhibited fluctuating performance over the past five years. In 2023, the operating ROA was significantly negative at -46.71%, indicating that the company generated operating losses relative to its asset base. This represents a deterioration from the previous year, where the operating ROA was also negative at -31.55%.

The company's operational efficiency improved notably in 2021, with an operating ROA of 14.36%, highlighting Regenxbio's ability to generate operating income from its assets. However, this positive trend was not sustained in the following years.

In 2020 and 2019, the operating ROA was notably negative at -16.84% and -29.93%, respectively, indicating operational inefficiencies and potential challenges in utilizing its assets effectively to generate profits.

Overall, the trend in Regenxbio Inc's operating ROA suggests inconsistency in operational performance and underscores the importance of closely monitoring and analyzing the company's efficiency in utilizing its assets to drive profitability.